M. Choi
3 Papers
M. Choi is an academic researcher. The author has contributed to research in topics: Medicine & Induced pluripotent stem cell. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
Peter W. Andrews,David Baker,N. Benvinisty,B. Miranda,K. Bruce,Oliver Brüstle,M. Choi,Y. M. Choi,Jeremy M. Crook,P.A. De Sousa,Petr Dvorak,Christian Freund,Meri T. Firpo,Miho Furue,Paul J. Gokhale,H. Y. Ha,E. Han,Simone Haupt,L. Healy,Derek J. Hei,Outi Hovatta,C. Hunt,S. M. Hwang,Maneesha S. Inamdar,Rosario Isasi,Marisa Jaconi,V. Jekerle,P. Kamthorn,M. C. Kibbey,Ivana Knezevic,B. B. Knowles,S. K. Koo,Y. Laabi,L. Leopoldo,Pentao Liu,Geoffrey P. Lomax,Jeanne F. Loring,Tenneille Ludwig,Karen Dyer Montgomery,Christine L. Mummery,Andras Nagy,Y. Nakamura,Norio Nakatsuji,Steve Oh,Sun Kyung Oh,Timo Otonkoski,Martin F. Pera,Marc Peschanski,Patricia Pranke,Kristiina Rajala,Mahendra Rao,R. Ruttachuk,Benjamin Reubinoff,L. Ricco,Heather M. Rooke,Douglas Sipp,Glyn Stacey,Hirofumi Suemori,Tsuneo Takahashi,K. Takada,S. Talib,Shelly E. Tannenbaum,B. Z. Yuan,Fanyi Zeng,Qi Zhou +64 more
TL;DR: This guidance is revisited to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications.
Is aryl hydrocarbon receptor antagonism after ischemia effective in alleviating acute hepatic ischemia-reperfusion injury in rats?
Jae-Im Kwon,Hwon Heo,Yeon Ji Chae,Joongkee Min,Do-Wan Lee,Sang Tae Kim,M. Choi,Yu Sub Sung,Kyung Won Kim,Yoon-Seok Choi,Dong-Cheol Woo,Chul-Woong Woo +11 more
TL;DR: Aryl hydrocarbon receptors (AhRs) have been reported to be important mediators of ischemic injury in the brain, and pharmacological inhibition of AhR activation has been shown to attenuate cerebral ischemia-reperfusion (IR) injury as mentioned in this paper .
1
Preclinical Long-term Magnetic Resonance Imaging Study of Silymarin Liver-protective Effects
Yeon Ji Chae,Hwon Heo,Chul-Woong Woo,Sang Tae Kim,Jae-Im Kwon,M. Choi,Yu Sub Sung,Kyung Won Kim,Jeong Kon Kim,Yoon-Seok Choi,Dong-Cheol Woo +10 more
TL;DR: In this article , Silymarin had hepatoprotective effects on TAA-induced liver injury and demonstrated the usefulness of multiparametric MRI to evaluate efficacy in preclinical studies of liver drug development.